Home › Atrial Fibrillation › Connecticut
Atrial Fibrillation clinical trials in Connecticut
5 studies for Atrial Fibrillation are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Hartford Hospital, Hartford
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 25, 2026 · NCT07527299Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1012, Stamford
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Yale Medicine, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT04045665Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Hartford Hospital, Hartford
- Yale New Haven Hospital, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- Hartford Health Care, Hartford
Recruiting
Ages 18 and older · All sexes · Updated May 9, 2025 · NCT06957366From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.